Unknown

Dataset Information

0

Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption.


ABSTRACT: Combination antiretroviral therapy controls but does not cure HIV-1 infection because a small fraction of cells harbor latent viruses that can produce rebound viremia when therapy is interrupted. The circulating latent virus reservoir has been documented by a variety of methods, most prominently by viral outgrowth assays (VOAs) in which CD4+ T cells are activated to produce virus in vitro, or more recently by amplifying proviral near full-length (NFL) sequences from DNA. Analysis of samples obtained in clinical studies in which individuals underwent analytical treatment interruption (ATI), showed little if any overlap between circulating latent viruses obtained from outgrowth cultures and rebound viruses from plasma. To determine whether intact proviruses amplified from DNA are more closely related to rebound viruses than those obtained from VOAs, we assayed 12 individuals who underwent ATI after infusion of a combination of two monoclonal anti-HIV-1 antibodies. A total of 435 intact proviruses obtained by NFL sequencing were compared with 650 latent viruses from VOAs and 246 plasma rebound viruses. Although, intact NFL and outgrowth culture sequences showed similar levels of stability and diversity with 39% overlap, the size of the reservoir estimated from NFL sequencing was larger than and did not correlate with VOAs. Finally, intact proviruses documented by NFL sequencing showed no sequence overlap with rebound viruses; however, they appear to contribute to recombinant viruses found in plasma during rebound.

SUBMITTER: Lu CL 

PROVIDER: S-EPMC6275529 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruption.

Lu Ching-Lan CL   Pai Joy A JA   Nogueira Lilian L   Mendoza Pilar P   Gruell Henning H   Oliveira Thiago Y TY   Barton John J   Lorenzi Julio C C JCC   Cohen Yehuda Z YZ   Cohn Lillian B LB   Klein Florian F   Caskey Marina M   Nussenzweig Michel C MC   Jankovic Mila M  

Proceedings of the National Academy of Sciences of the United States of America 20181112 48


Combination antiretroviral therapy controls but does not cure HIV-1 infection because a small fraction of cells harbor latent viruses that can produce rebound viremia when therapy is interrupted. The circulating latent virus reservoir has been documented by a variety of methods, most prominently by viral outgrowth assays (VOAs) in which CD4<sup>+</sup> T cells are activated to produce virus in vitro, or more recently by amplifying proviral near full-length (NFL) sequences from DNA. Analysis of s  ...[more]

Similar Datasets

| S-EPMC7325710 | biostudies-literature
| S-EPMC6450127 | biostudies-literature
| S-EPMC10792747 | biostudies-literature
| S-EPMC5960642 | biostudies-literature
| S-EPMC4633715 | biostudies-literature
| S-EPMC7375368 | biostudies-literature
| S-EPMC8479831 | biostudies-literature
| S-EPMC3838251 | biostudies-literature
| S-EPMC5292134 | biostudies-literature
| S-EPMC8094949 | biostudies-literature